• Home
  • FPA144, a humanized monoclonal antibody for both FGFR2 -amplified and nonamplified, FGFR2b -overexpressing gastric cancer patients.

FPA144, a humanized monoclonal antibody for both FGFR2 -amplified and nonamplified, FGFR2b -overexpressing gastric cancer patients.

Author List
Kristen L. Pierce, Amit M. Deshpande, Bradley A. Stohr, Abigael T. Gemo, Namrata S. Patil, Thomas J. Brennan, David I. Bellovin, Servando Palencia, Tina Giese, Carol Huang, Kevin P. Baker, W. Michael Kavanaugh, Julie Hambleton, Gerrit Los
Publication
Journal of Clinical Oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/79290295
Publication Year
2014
Publication Title
Kristen L. Pierce, Amit M. Deshpande, Bradley A. Stohr, Abigael T. Gemo, Namrata S. Patil, Thomas J. Brennan, David I. Bellovin, Servando Palencia, Tina Giese, Carol Huang, Kevin P. Baker, W. Michael Kavanaugh, Julie Hambleton, Gerrit Los. FPA144, a humanized monoclonal antibody for both FGFR2 -amplified and nonamplified, FGFR2b -overexpressing gastric cancer patients. Journal of Clinical Oncology. 2014 May 20; 32(15_suppl):e15074-e15074.